Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-30 Purchase | 2024-02-01 4:47 pm | ArriVent Biopharma Inc. | AVBP | HILLHOUSE INVESTMENT MANAGEMENT LTD. HHLR ADVISORS LTD. 10% Owner | 555,555 | $18 | $9,999,990 | 4,484,672 (Indirect) | View |
| 2024-01-30 Purchase | 2024-01-31 4:12 pm | ArriVent Biopharma Inc. | AVBP | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Advisors IV Ltd OrbiMed Asia GP IV L.P. Director 10% Owner | 444,444 | $18 | $7,999,992 | 1,513,664 (Indirect) | View |
| 2024-01-30 Purchase | 2024-01-31 4:11 pm | ArriVent Biopharma Inc. | AVBP | GORDON CARL L Director 10% Owner | 444,444 | $18 | $7,999,992 | 1,513,664 (Indirect) | View |
| 2024-01-30 Purchase | 2024-01-31 4:10 pm | ArriVent Biopharma Inc. | AVBP | HEALY JAMES Director | 444,444 | $18 | $7,999,992 | 1,696,752 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-22 Option Award | 2024-04-23 4:06 pm | N/A 2034-04-21 | ArriVent BioPharma Inc. | AVBP | Peterson Kristine Director | 28,587 | $0 | 28,587 (Direct) | View |
| 2024-01-30 Conversion | 2024-02-01 4:47 pm | N/A N/A | ArriVent Biopharma Inc. | AVBP | HILLHOUSE INVESTMENT MANAGEMENT LTD. HHLR ADVISORS LTD. 10% Owner | 63,691,020 | $0 | 4,484,672 (Indirect) | View |
| 2024-01-30 Conversion | 2024-01-31 4:12 pm | N/A N/A | ArriVent Biopharma Inc. | AVBP | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Advisors IV Ltd OrbiMed Asia GP IV L.P. Director 10% Owner | 2,582,884 | $0 | 1,513,664 (Indirect) | View |
| 2024-01-30 Conversion | 2024-01-31 4:11 pm | N/A N/A | ArriVent Biopharma Inc. | AVBP | GORDON CARL L Director 10% Owner | 2,582,884 | $0 | 1,513,664 (Indirect) | View |
| 2024-01-30 Conversion | 2024-01-31 4:10 pm | N/A N/A | ArriVent Biopharma Inc. | AVBP | HEALY JAMES Director | 1,252,308 | $0 | 1,696,752 (Indirect) | View |
| 2024-01-25 Option Award | 2024-01-29 4:16 pm | N/A 2034-01-24 | ArriVent Biopharma Inc. | AVBP | Nolet Chris Director | 17,884 | $0 | 17,884 (Direct) | View |
| 2024-01-25 Option Award | 2024-01-29 4:15 pm | N/A 2034-01-24 | ArriVent Biopharma Inc. | AVBP | Jallal Bahija Director | 17,884 | $0 | 17,884 (Direct) | View |
Ownership | 2024-01-25 9:01 pm | N/A N/A | ArriVent Biopharma Inc. | AVBP | HILLHOUSE INVESTMENT MANAGEMENT LTD. 10% Owner | 0 | $0 | 3,929,117 (Indirect) | View |
Ownership | 2024-01-25 8:40 pm | N/A N/A | ArriVent Biopharma Inc. | AVBP | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Advisors IV Ltd OrbiMed Asia GP IV L.P. Director 10% Owner | 0 | $0 | 2,582,884 (Indirect) | View |
Ownership | 2024-01-25 8:39 pm | N/A N/A | ArriVent Biopharma Inc. | AVBP | Yao Zhengbin President and CEO | 0 | $0 | 1,369,489 (Indirect) | View |
Ownership | 2024-01-25 8:39 pm | N/A 2033-09-07 | ArriVent Biopharma Inc. | AVBP | Nolet Chris Director | 0 | $0 | 16,436 (Direct) | View |
Ownership | 2024-01-25 8:39 pm | N/A N/A | ArriVent Biopharma Inc. | AVBP | Lutzker Stuart President of R&D | 0 | $0 | 373,251 (Direct) | View |
Ownership | 2024-01-25 8:38 pm | N/A N/A | ArriVent Biopharma Inc. | AVBP | LaChapelle Robin Chief Operating Officer | 0 | $0 | 661,636 (Direct) | View |
Ownership | 2024-01-25 8:38 pm | N/A 2034-01-03 | ArriVent Biopharma Inc. | AVBP | Kung Winston Chief Financial Officer | 0 | $0 | 197,238 (Direct) | View |
Ownership | 2024-01-25 8:38 pm | N/A N/A | ArriVent Biopharma Inc. | AVBP | Kastenmayer James Paul General Counsel | 0 | $0 | 106,004 (Direct) | View |
Ownership | 2024-01-25 8:37 pm | N/A N/A | ArriVent Biopharma Inc. | AVBP | HEALY JAMES Director | 0 | $0 | 1,252,308 (Indirect) | View |
Ownership | 2024-01-25 8:36 pm | N/A N/A | ArriVent Biopharma Inc. | AVBP | GORDON CARL L Director 10% Owner | 0 | $0 | 2,582,884 (Indirect) | View |
Ownership | 2024-01-25 8:36 pm | N/A 2032-01-31 | ArriVent Biopharma Inc. | AVBP | Jallal Bahija Director | 0 | $0 | 19,723 (Direct) | View |